|
CCDC12 expression based on
|
KIRP : Kidney renal papillary cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 9.449100E-04 |
|
KIRP : Kidney renal papillary cell carcinoma Note
Cancer stage information is not available for 89 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
8.42640000000561E-05 |
| Normal-vs-Stage2 |
4.802000E-01 |
| Normal-vs-Stage3 |
8.915000E-01 |
| Normal-vs-Stage4 |
6.602600E-01 |
| Stage1-vs-Stage2 |
4.916200E-02 |
| Stage1-vs-Stage3 |
3.801500E-04 |
| Stage1-vs-Stage4 |
2.442400E-02 |
| Stage2-vs-Stage3 |
5.715000E-01 |
| Stage2-vs-Stage4 |
3.998600E-01 |
| Stage3-vs-Stage4 |
6.072400E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient race information is not available for 15 samples and two samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
6.197600E-04 |
| Normal-vs-AfricanAmerican |
2.135800E-02 |
| Normal-vs-Asian |
2.782600E-01 |
| Caucasian-vs-AfricanAmerican |
5.166000E-01 |
| Caucasian-vs-Asian |
7.055000E-01 |
| AfricanAmerican-vs-Asian |
8.833400E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
1.363280E-03 |
| Normal-vs-Female |
6.055200E-03 |
| Male-vs-Female |
7.882000E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient BMI information is not available for 72 samples.
| Descriptions |
| Normal weight |
BMI greater than equal to 18.5 and BMI less than 25 |
Extereme weight |
BMI greater than equal to 25 and BMI less than 30 |
| Obese |
BMI greater than equal to 30 and BMI less than 40 |
Extreme Obese |
BMI greater than 40 |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Normal_Weight |
6.001400E-03 |
| Normal-vs-Extreme_Weight |
5.386300E-04 |
| Normal-vs-Obese |
3.300500E-02 |
| Normal-vs-Extreme_Obese |
8.740200E-02 |
| Normal_Weight-vs-Extreme_Weight |
9.789400E-01 |
| Normal_Weight-vs-Obese |
3.585800E-01 |
| Normal_Weight-vs-Extreme_Obese |
6.722400E-01 |
| Extreme_Weight-vs-Obese |
2.135400E-01 |
| Extreme_Weight-vs-Extreme_Obese |
5.467000E-01 |
| Obese-vs-Extreme_Obese |
9.037600E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient age information is not available for 3 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
9.318200E-02 |
| Normal-vs-Age(41-60Yrs) |
7.418100E-03 |
| Normal-vs-Age(61-80Yrs) |
5.228000E-04 |
| Normal-vs-Age(81-100Yrs) |
2.975600E-01 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
6.431800E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
9.547400E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
4.769000E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
2.802600E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
5.768800E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
3.360200E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma NOTE
Histology information is not available for 17 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-VS-Type1 PRCC |
9.35010000535641E-08 |
| Normal-VS-Type2 PRCC |
1.178360E-01 |
| Normal-VS-KIRP CIMP |
8.475600E-01 |
| Normal-VS-Unclassified PRCC |
3.568200E-01 |
| Type1 PRCC-VS-Type2 PRCC |
<1E-12 |
| Type1 PRCC-VS-KIRP CIMP |
6.600600E-03 |
| Type1 PRCC-VS-Unclassified PRCC |
3.1211000000031E-06 |
| Type2 PRCC-VS-KIRP CIMP |
4.222400E-01 |
| Type2 PRCC-VS-Unclassified PRCC |
5.599100E-03 |
| KIRP CIMP-VS-Unclassified PRCC |
4.098200E-01 |
|
Histologic PRCC subtypes: Ricketts CJ et al, The Cancer Genome Atlas Comprehensive Molecular Characterization of Renal Cell Carcinoma. Cell Rep. 2018 Apr 3;23(1):313-326.e5. doi: 10.1016/j.celrep.2018.03.075
|
KIRP : Kidney renal papillary cell carcinoma Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 211 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
8.001800E-02 |
| Normal-vs-N1 |
6.422600E-01 |
| Normal-vs-N2 |
3.365400E-01 |
| N0-vs-N1 |
4.570300E-02 |
| N0-vs-N2 |
1.401030E-01 |
| N1-vs-N2 |
4.377000E-01 |
|
|
